{
    "Trade/Device Name(s)": [
        "Prodigy\u00ae AutoCode\u00ae Eject Blood Glucose Monitoring System",
        "Prodigy\u00ae No Coding Test Strips"
    ],
    "Submitter Information": "OK Biotech Co., Ltd.",
    "510(k) Number": "K141914",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122338"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "March 1, 2015",
    "Summary Letter Received Date": "March 11, 2015",
    "Submission Date": "April 14, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Prodigy\u00ae No Coding Test Strips"
    ],
    "Instrument(s)/Platform(s)": [
        "Prodigy\u00ae AutoCode\u00ae Eject Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical method",
        "Dry reagent biosensor"
    ],
    "Methodologies": [
        "Electrochemical glucose measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Reagent",
        "Strip test",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Prodigy AutoCode Eject Blood Glucose Monitoring System and No Coding Test Strips for self-testing of glucose levels in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips and alternative sites for self-testing at home by people with diabetes, as an aid to monitor effectiveness of diabetes control; not for diagnosis, screening for diabetes, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}